Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG
Capital International Investors reported a 7.70% stake in Hemab Therapeutics Holdings, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 12, 2026
Capital International Investors reported a 7.70% stake in Hemab Therapeutics Holdings, Inc., 3,603,876 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G).
- Stake
- 7.70%
- Shares
- 3,603,876
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Capital International Investors | 7.70% | 3,603,876 |
Source
Related
- Hemab Therapeutics Holdings, Inc.
- Capital International Investors
- Hemab Therapeutics Holdings, Inc. shareholders
- Schedule 13G · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Invus Public Equities, L.P. · Aug 7, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026
- Schedule 13G · Sofinnova Crossover II SLP · Aug 5, 2026